NEW ORAL CONTRACEPTIVE: SEQUENTIAL ESTROGEN AND PROGESTIN. 1964

J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE

UI MeSH Term Description Entries
D008599 Menstruation Disturbances Variations of MENSTRUATION which may be indicative of disease. Hypomenorrhea,Menstruation Disorders,Menstruation, Retrograde,Polymenorrhea,Irregular Menses,Irregular Menstruation,Menstrual Irregularities,Menstrual Irregularity,Disorder, Menstruation,Disorders, Menstruation,Disturbance, Menstruation,Disturbances, Menstruation,Irregularity, Menstrual,Menses, Irregular,Menstruation Disorder,Menstruation Disturbance,Menstruation, Irregular,Retrograde Menstruation
D008656 Mestranol The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy-, (17alpha)-,Ethinyl Estradiol 3-Methyl Ether,Ethinyl Estradiol 3 Methyl Ether
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011372 Progestins Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. Gestagenic Agent,Progestagen,Progestagenic Agent,Progestational Agent,Progestational Compound,Progestational Hormone,Progestogen,Progestogens,Gestagen,Gestagen Effect,Gestagen Effects,Gestagenic Agents,Gestagenic Effect,Gestagenic Effects,Gestagens,Progestagenic Agents,Progestagens,Progestational Agents,Progestational Compounds,Progestational Hormones,Progestin,Progestin Effect,Progestin Effects,Progestogen Effect,Progestogen Effects,Agent, Gestagenic,Agent, Progestagenic,Agent, Progestational,Compound, Progestational,Effect, Gestagen,Effect, Gestagenic,Effect, Progestin,Effect, Progestogen,Effects, Gestagen,Effects, Gestagenic,Effects, Progestin,Effects, Progestogen,Hormone, Progestational
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002715 Chlormadinone Acetate An orally active synthetic progestational hormone used often in combinations as an oral contraceptive (CONTRACEPTIVES, ORAL). Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-chloro-,Chlormadinon Acetate,Chlormadinone,Chlormadinone Acetate, (9 beta,10 alpha)-Isomer,Neo-Eunomin,Neo Eunomin,NeoEunomin
D003270 Contraceptive Agents Chemical substances that prevent or reduce the probability of CONCEPTION. Contraceptive,Contraceptive Effect,Contraceptive Effects,Contraceptives,Agents, Contraceptive,Effect, Contraceptive,Effects, Contraceptive
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D004358 Drug Therapy The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D004412 Dysmenorrhea Painful menstruation. Menstruation, Painful,Pain, Menstrual,Dysmenorrheas,Menstrual Pain,Menstrual Pains,Menstruations, Painful,Painful Menstruation,Painful Menstruations,Pains, Menstrual

Related Publications

J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
January 1969, Transactions of the American Neurological Association,
J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
June 2002, The Medical letter on drugs and therapeutics,
J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
February 2020, The Medical letter on drugs and therapeutics,
J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
May 2020, JAMA,
J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
March 1965, Metabolism: clinical and experimental,
J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
January 1966, Pennsylvania medicine,
J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
January 1968, International journal of fertility,
J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
April 2003, The American journal of nursing,
J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
March 2020, The Medical letter on drugs and therapeutics,
J W GOLDZIEHER, and C BECERRA, and C GUAL, and N B LIVINGSTON, and M MAQUEO, and L E MOSES, and C TIETZE
January 1969, Fertility and sterility,
Copied contents to your clipboard!